DeGette, Bucshon Release Statement on Burdensome FDA Rule Regulating Lab-Developed Tests
April 29, 2024
April 29, 2024
WASHINGTON, April 29 -- Rep. Diana DeGette, D-Colorado, issued the following news release:
Today, Congresswoman Diana DeGette (CO-01) and Congressman Larry Bucshon, M.D. (IN-08) released the following statement after the Food and Drug Administration (FDA) finalized a rule regulating lab-developed tests (LDTs), a subset of in-vitro clinical tests (IVCTs).
"Rational oversight of in-vitro diagnostics, including laboratory-developed tests, is vital for innovation in di . . .
Today, Congresswoman Diana DeGette (CO-01) and Congressman Larry Bucshon, M.D. (IN-08) released the following statement after the Food and Drug Administration (FDA) finalized a rule regulating lab-developed tests (LDTs), a subset of in-vitro clinical tests (IVCTs).
"Rational oversight of in-vitro diagnostics, including laboratory-developed tests, is vital for innovation in di . . .
